Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Merimepodib (VX-497): IMPDH Research Workflows
2026-08-17
Merimepodib (VX-497) gives researchers a selective way to test how guanine nucleotide depletion affects lymphocyte proliferation, viral replication, and broader disease models. This workflow-focused guide covers dose design, guanosine rescue, PEDV assays, formulation controls, and troubleshooting for reproducible IMPDH research.
-
RIPA Lysis Buffer Strong: Assay-Design Guide
2026-08-17
RIPA Lysis Buffer Strong combines powerful membrane solubilization with flexible inhibitor customization. This assay-design guide connects its chemistry to Western blotting, immunoprecipitation, ELISA, kinase workflows, and mechanistic insights from uPAR–uPA cancer research.
-
NBC19 NLRP3 Inflammasome Inhibitor Workflow
2026-08-16
NBC19 provides a practical way to separate NLRP3-dependent IL-1β release from upstream priming and downstream inflammatory effects. This workflow combines differentiated THP1 assays with a carefully bounded extension into lactate-HMGB1 and sepsis research, emphasizing controls, fresh compound handling, and stimulus-specific optimization.
-
Multiple Myeloma Cell Lines: Mutations and Drug Resistance
2026-08-15
This Theranostics study built a broad exome-based view of genetic variation across human multiple myeloma cell lines and connected recurrent alterations with signaling pathways and drug response. Its main practical contribution is a framework for selecting molecularly appropriate models for hematological malignancy research rather than relying on a small, poorly characterized set of cell lines.
-
β-Elemene C5505: Reliable Cell Assay Workflows
2026-08-14
This scenario-driven guide explains how β-Elemene (SKU C5505) can improve reproducibility in viability, adipogenesis, apoptosis, and pathway-focused assays. It combines product-specific handling data with findings from a 3T3-L1 study to support better concentration selection, solvent control, interpretation, and vendor evaluation.
-
MK-571: A Dual-Pathway Assay Strategy
2026-08-14
MK-571 (L-660,711) is more than a leukotriene D4 receptor antagonist: its ABCC1/MRP1 activity can materially shape macrophage chemotherapy assays. This guide explains how to separate receptor pharmacology from transporter-dependent redox protection in inflammation and drug-resistance research.
-
Anti-ROR1 Antibody: Assay Design Beyond Binding
2026-08-13
Anti-ROR1 Antibody (Zilovertamab) can support a layered strategy that separates target binding, pathway modulation, and phenotype. This article also explains how mechanistic lessons from DON-induced liver injury improve causal assay design without implying that ROR1 mediates toxin hepatotoxicity.
-
Dimethyloxalylglycine (DMOG) Protocol Guide
2026-08-13
Dimethyloxalylglycine (DMOG), SKU A4506, is a cell-permeable PHD inhibitor used for hypoxia-inducible factor stabilization in research models, with dossier-supported in vitro activity at 0.1–1 mmol/L. This guide covers solution handling, controls, QC, and interpretation for hypoxia signaling and inflammation and infection research; DMOG is not intended for clinical or diagnostic use.
-
Caspase-4 Colorimetric Assay Kit Guide
2026-08-12
Learn how SKU K2199 supports quantitative, LEVD-dependent caspase-4 activity detection in pyroptosis, inflammation, and cell-death studies. This scenario-based guide covers assay selection, protocol controls, data interpretation, and practical limitations for reliable laboratory workflows.
-
Protein A/G Magnetic Beads: Practical Workflow
2026-08-12
APExBIO K1305 Protein A/G Magnetic Beads support Fc-directed antibody capture for purification, immunoprecipitation, co-immunoprecipitation, and chromatin immunoprecipitation workflows. They are intended for research use with compatible IgG antibodies and should not be treated as diagnostic or medical products; antibody subclass, Fc accessibility, sample composition, and assay conditions require experimental verification.
-
Epacadostat: Designing Context-Aware IDO1 Assays
2026-08-11
Epacadostat (INCB024360) is an oral IDO1 inhibitor for dissecting tryptophan metabolism and tumor-associated immune suppression. This guide presents a context-aware assay strategy that connects biochemical potency with whole-blood cytokine biology and translational immuno-oncology decisions.
-
Phosphotungstic Acid Negative Stain Solution for Virology
2026-08-11
Conserved coronavirus glycans create a compelling translational target, but mechanism-driven virology also requires robust structural quality control. This thought-leadership guide explains how 2% phosphotungstic acid negative staining can support virus imaging, particle assessment, and decision-making without overstating what routine electron microscopy can prove.
-
Acetylspiramycin: From Ribosome to Translation
2026-08-10
Acetylspiramycin, or Spiramycin B, is more than a macrolide reference compound. Its 50S-ribosome mechanism, activity against challenging bacterial models, and relevance to component-defined antibiotic production make it a strategic tool for antimicrobial resistance research and translational assay design.
-
FITC Goat Anti-Rabbit IgG (H+L) Antibody Workflow
2026-08-09
Build clearer immunofluorescence, flow cytometry, and tissue-imaging workflows with a fluorescein-conjugated secondary antibody designed for rabbit primary antibodies. This guide connects practical detection choices with the IL-11/GP130 fibrosis study while emphasizing controls, quantification, storage, and troubleshooting.
-
PEDV Hijacks IMPDH-Dependent Nucleotide Biosynthesis
2026-08-08
The reference study identifies IMPDH-dependent guanine nucleotide biosynthesis as a host pathway that porcine epidemic diarrhea virus (PEDV) requires for efficient replication. By combining comparative metabolomics, IMPDH2 knockdown, and pharmacological inhibition with Merimepodib (VX-497), the authors provide evidence for a host-directed antiviral vulnerability while also revealing cell-specific metabolic responses.